-

Announcing Coefficient, a Verily Subsidiary Focused on Employer Stop-Loss and Backed by Swiss Re Corporate Solutions

Coefficient established to help employers realize greater value through “precision risk,” a new data-driven solution to employer stop-loss insurance

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)--Verily, an Alphabet company, is announcing a new subsidiary, Coefficient Insurance Company, that will be backed by Swiss Re Corporate Solutions, the commercial insurance unit of the Swiss Re Group. Coefficient will combine innovative health technology solutions with novel insurance and payment models. Its precision risk solution helps self-funded employers to control cost volatility through a data-driven model that is unique in the traditional employer stop-loss market. Employer stop-loss is a segment of commercial insurance that protects self-funded employers from unexpected and large employee health benefit claims by reimbursing employers for claims above a defined amount.

Coefficient will leverage Verily’s core strengths integrating hardware, software and data science and will also leverage Swiss Re Corporate Solutions’s risk knowledge, distribution capabilities and reputation in the employer stop-loss market.

Coefficient’s precision risk solution is designed to provide self-funded employers with more predictable benefit plan protection. It uses an analytics-based underwriting engine to identify unexpected areas of cost volatility, and cover those exposures with more dynamic and precise insurance policy provisions. Over time, Coefficient plans to integrate Verily’s suite of health devices and tech-driven interventions for workers and dependents into its precision risk solution to improve health outcomes and control cost.

“Employers have been facing rising and increasingly unpredictable healthcare costs for years,” said Andy Conrad, CEO, Verily. “Coefficient is aimed at reducing blind spots and providing greater cost control mechanisms for self-funded employers, and we expect that partnering with Swiss Re Corporate Solutions will help us to better develop and distribute our precision risk solution to the employer stop-loss market. Over time, we look forward to integrating Coefficient with Verily’s employer health solutions, including mobile health devices and innovative care management programs, in order to align payment models with better health outcomes.”

"Swiss Re Corporate Solutions has long prided itself for being a knowledge-based and data-driven insurer. Today, we're building on that strong foundation by partnering with Alphabet's Verily to use advanced technology and data analytics to innovate risk management in the employer stop-loss space," stated Andreas Berger, CEO, Swiss Re Corporate Solutions. "We look forward to working with Coefficient in delivering on our mission to address industry inefficiencies, provide an outstanding customer experience and advance corporate insurance together.”

Swiss Re Corporate Solutions has agreed to make a minority investment in Coefficient, subject to the satisfaction of certain closing conditions including regulatory approvals. In connection with this investment, Ivan Gonzalez, CEO North America, Swiss Re Corporate Solutions, is expected to join the Coefficient Board of Directors upon closing.

About Coefficient

Coefficient plans to provide self-funded employers with a new data-based approach to employer stop-loss in order to help them manage risks, costs and achieve better outcomes. To learn more, visit https://getcoefficient.com/.

About Verily

Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Our mission is to make the world’s health data useful so that people enjoy healthier lives. Verily develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. We partner with leading life sciences, medical device and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.

About Swiss Re Corporate Solutions

Swiss Re Corporate Solutions provides risk transfer solutions to large and mid-sized corporations around the world. Its innovative, highly customised products and standard insurance covers help to make businesses more resilient, while its industry-leading claims service provides additional peace of mind. Swiss Re Corporate Solutions serves clients from offices worldwide and is backed by the financial strength of the Swiss Re Group. Visit corporatesolutions.swissre.com or follow us on LinkedIn and Twitter @SwissRe_CS.

Contacts

Media Contacts
Robin Suchan
Public Affairs and Communications, Verily
Email: suchan@verily.com
Direct: 415-736-1547

Shannon O’Hara, Ph.D.
Communications, Swiss Re Corporate Solutions
Email: Shannon_OHara@swissre.com
Mobile: +1 646 932 7225

Verily


Release Versions

Contacts

Media Contacts
Robin Suchan
Public Affairs and Communications, Verily
Email: suchan@verily.com
Direct: 415-736-1547

Shannon O’Hara, Ph.D.
Communications, Swiss Re Corporate Solutions
Email: Shannon_OHara@swissre.com
Mobile: +1 646 932 7225

More News From Verily

Mayo Clinic, Verily to Build Advanced Clinical Decision Support to Enhance Care

ROCHESTER, Minn.--(BUSINESS WIRE)--Mayo Clinic and Verily, an Alphabet company founded at the convergence of health care, data science and technology, today announced a strategic two-year collaboration. This collaboration focuses on the development of a digital point-of-care resource of vetted knowledge to support an individualized approach to patient care. This modular, evidence-based decision support solution, will provide contextualized and validated knowledge on disease management, care gui...

Verily to Acquire SignalPath, Expanding Company’s Clinical Research Capabilities

SOUTH SAN FRANCISCO, Calif. & RALEIGH, N.C.--(BUSINESS WIRE)--Verily, an Alphabet company, and SignalPath today announced that they have entered into an agreement in which Verily will acquire SignalPath, a privately held company based in Raleigh that has developed the SignalPath platform, a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. “Joining forces helps to accelerate and scale our shared vision, increas...

Colgate-Palmolive to Leverage Verily’s Baseline Platform for Innovative Study in Oral Health Research

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)--Verily, an Alphabet company, and Colgate-Palmolive, the global leader in oral care, today announced a strategic collaboration to advance oral health research. Under the agreement, Colgate's Dental Clinical Team will partner with Verily to conduct an innovative oral health study as part of Verily’s ongoing Baseline Health Study that will aim to improve understanding of connections between oral health and overall human health. The study’s g...
Back to Newsroom